These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9630803)

  • 21. Tumour vascularisation: a druggable target.
    Bishop-Bailey D
    Curr Opin Pharmacol; 2009 Apr; 9(2):96-101. PubMed ID: 19056315
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cancer angiogenesis: targeting the heel of Achilles.
    Dass CR; Choong PF
    J Drug Target; 2008 Jul; 16(6):449-54. PubMed ID: 18604657
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Tumour angiogenesis and therapy directed at the neovasculature].
    Eikesdal HP; Dahl O; Straume O; Akslen LA
    Tidsskr Nor Laegeforen; 2004 Aug; 124(15):1919-22. PubMed ID: 15306859
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hemostatic complications of angiogenesis inhibitors in cancer patients.
    Elice F; Jacoub J; Rickles FR; Falanga A; Rodeghiero F
    Am J Hematol; 2008 Nov; 83(11):862-70. PubMed ID: 18819092
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Angiogenesis and gliomas: current issues and development of surrogate markers.
    Jouanneau E
    Neurosurgery; 2008 Jan; 62(1):31-50; discussion 50-2. PubMed ID: 18300890
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Angiogenesis-inhibiting drugs--a future therapeutic option].
    Perbeck L
    Nord Med; 1998 Nov; 113(9):297-8, 316. PubMed ID: 9835760
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Angiogenesis inhibition in solid tumors.
    Rosen LS
    Cancer J; 2001; 7 Suppl 3():S120-8. PubMed ID: 11779082
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The clinical implications of angiogenesis in the treatment of cancer.
    Aoun E; Taher A
    J Med Liban; 2002; 50(1-2):32-8. PubMed ID: 12841311
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vascular remodeling and clinical resistance to antiangiogenic cancer therapy.
    Glade Bender J; Cooney EM; Kandel JJ; Yamashiro DJ
    Drug Resist Updat; 2004; 7(4-5):289-300. PubMed ID: 15533766
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combining radiotherapy and angiogenesis inhibitors: clinical trial design.
    Citrin D; Ménard C; Camphausen K
    Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):15-25. PubMed ID: 16377411
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiangiogenic strategies, compounds, and early clinical results in breast cancer.
    Morabito A; Sarmiento R; Bonginelli P; Gasparini G
    Crit Rev Oncol Hematol; 2004 Feb; 49(2):91-107. PubMed ID: 15012971
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Neoplasms and angiogenesis].
    Lewy-Trenda I
    Pol Merkur Lekarski; 2002 Sep; 13(75):225-8. PubMed ID: 12474576
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Current development status of small-molecule vascular disrupting agents.
    Chaplin DJ; Horsman MR; Siemann DW
    Curr Opin Investig Drugs; 2006 Jun; 7(6):522-8. PubMed ID: 16784022
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The rationale and future potential of angiogenesis inhibitors in neoplasia.
    Gasparini G
    Drugs; 1999 Jul; 58(1):17-38. PubMed ID: 10439927
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of copper in tumour angiogenesis--clinical implications.
    Nasulewicz A; Mazur A; Opolski A
    J Trace Elem Med Biol; 2004; 18(1):1-8. PubMed ID: 15487757
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Angiogenesis: pathological, prognostic, and growth-factor pathways and their link to trial design and anticancer drugs.
    Fox SB; Gasparini G; Harris AL
    Lancet Oncol; 2001 May; 2(5):278-89. PubMed ID: 11905783
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The modulation of granulomatous tissue and tumour angiogenesis by diclofenac in combination with hyaluronan (HYAL EX-0001).
    Freemantle C; Alam CA; Brown JR; Seed MP; Willoughby DA
    Int J Tissue React; 1995; 17(4):157-66. PubMed ID: 8867646
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radiobiology and vascular targeting in glioma.
    Short SC; Harney J
    Curr Opin Neurol; 2003 Dec; 16(6):651-5. PubMed ID: 14624072
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Metronomic chemotherapy in 2011: update and perspectives].
    Benbrahim Z; Massard C; El Mesbahi O
    Bull Cancer; 2011 Dec; 98(12):1447-54. PubMed ID: 22146261
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical perspectives of tumor angiogenesis in pediatric oncology.
    Schweigerer L
    Klin Padiatr; 1997; 209(4):257-64. PubMed ID: 9293459
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.